VAERS reports by lot
Sanofi Pasteur DTaP/Tdap lot 3CA20C1: VAERS reports
25 VAERS reports list lot 3CA20C1 as a Sanofi Pasteur DTaP/Tdap vaccine, received between 2025-04-14 and 2026-03-28. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).
Symptom categories in these reports
A report can mention several categories, so the counts add up to more than the number of reports.
| Category | Count | % |
|---|---|---|
| Injection-site / Local reaction | 21 | 66% |
| Allergic / Anaphylactic | 6 | 19% |
| Dermatological (non-injection-site) | 3 | 9% |
| Musculoskeletal | 1 | 3% |
| General / Systemic (non-local) | 1 | 3% |
Where reports came from
U.S. state of the reporter, where given (top 12).
| State | Reports |
|---|---|
| Nevada | 3 |
| Virginia | 2 |
| Missouri | 2 |
| Colorado | 2 |
| Pennsylvania | 2 |
| New Jersey | 2 |
| Michigan | 2 |
| Ohio | 2 |
| Alabama | 1 |
| California | 1 |
| Texas | 1 |
| Arizona | 1 |
Reports by month received
| Month | Reports | Bar |
|---|---|---|
| 2025-04 | 3 | |
| 2025-05 | 5 | |
| 2025-06 | 4 | |
| 2025-07 | 4 | |
| 2025-08 | 1 | |
| 2025-09 | 1 | |
| 2025-10 | 1 | |
| 2025-11 | 2 | |
| 2026-03 | 4 |
Products recorded with this lot
- DTaP — Sanofi Pasteur (25 reports)
Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.
Related
- All Sanofi Pasteur DTaP/Tdap lots with VAERS reports
- DTaP/Tdap vaccine lot number lookup
- DTaP/Tdap vaccine side effects, trials and ingredients
- Daptacel: ingredients, package insert and side effects
- Look up a lot for any vaccine
Nearby Sanofi Pasteur DTaP/Tdap lots (A–Z): 2CA28C1 · 2CA77C1 · 3CA03C3 · 3CA25C1 · 3CA55C1 · C2340AA
Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.